Echocardiographic Measurement of Myocardial Work
Launched by CENTRE HOSPITALIER UNIVERSITAIRE DE NICE · May 14, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a new way to measure how well the heart is working in patients who are critically ill, especially those in shock. The researchers want to see if this new method, which uses echocardiography (a type of ultrasound for the heart), can give better information about heart function than traditional methods. They will measure different aspects of the heart's work, which may help doctors understand the impact of treatments like fluids or medications on heart performance.
To participate in the trial, patients aged 65 and older who need fluid or norepinephrine (a medication to help raise blood pressure) may be eligible. However, some patients will not be included, such as those with certain heart conditions or who have ordered not to be resuscitated. If enrolled, participants can expect to undergo non-invasive heart measurements while receiving their usual care in the intensive care unit. This study is important because it may improve how doctors manage heart function in critically ill patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Indication to fluid administration left to the discretion of the attending physician
- • Indication to norepinephrine administration or increase in norepinephrine dosage left to the discretion of the attending physician.
- Exclusion Criteria:
- • Patients under protection.
- • Patients with do not ressuscitate order.
- • Patients with severe left-side or right-side valvulopathy.
- • Patients with atrial fibrillation.
- • Patients with ventricular aneuvrysm or severe regional wall motion abnormalities.
- • Patients with a pacemaker.
- • Patients' objections to the collection of their health data.
About Centre Hospitalier Universitaire De Nice
The Centre Hospitalier Universitaire (CHU) de Nice is a leading academic medical center located in Nice, France, dedicated to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, CHU de Nice is committed to enhancing patient care by conducting rigorous studies that explore new therapies and treatment modalities across various medical disciplines. With a focus on collaboration, the center integrates cutting-edge technology and interdisciplinary expertise to ensure the highest standards of research integrity and patient safety. CHU de Nice plays a vital role in the development of evidence-based medicine, contributing significantly to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Marseille, , France
Nice, Chu De Nice, France
Nice, Chu De Nice, France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported